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Thicrurea derived compounds are known for Pheii 
goitrogenic activity [I]. These substances block the 
biosynthesis of thyroxine (T,) by inhibiting thyroid 
peroxidase [Z]. Among them rare the 2-bhiouracil 
(TU) derivatives, which have an additional inhibitory 
zffect on the deiodinactive metabolism of tky)iroid 
hormone in peripheral tissues [3,4]. T4 is considered 
as a prohormone, which is converted into the biolog- 
ically active form of thyroid hormone, 3,3’,5triiodo- 
thyronine (T,), by the enzyme iodothyronine 
5’deiodinase [5]. Deiodination of Tq may also yield 
the inactive rnetabolite 3,3’.5’-triiodothyronine (rT3). 
This latter reaction is probably mediated by a second 
enzyme, iodothyronine 5-deiodinase 151. The main 
pathway of rT; degradation is by 5’-deiodination into 
3,3’-diiodothyronine [511. The latter may also be 
poduced by 5-deiodination of T, 151: 
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These enzymes contain essential sulfbydryl groups 
and thiol cofactors are required for activity is]_ 
Deiodination follows a ping-pong mechanism \=&ich 
involves the oxidation of an enzyme-sulfllydryl group 
[G-83. This is kbstantiated by the findings of an 
uncompetitive inhibition by T&r of the 5’-deiodina- 
tion of Tq 1693 and of 3,3’,5’-triiodothyronine (rT,) 
[7;10]. This inhibition is competitively obviated by 
tbiols such as dithiot%eitol (DTT) and by 1 -methyl- 
2mercaptohnlidazole (MMT) or thiourea [6-$31. A 
sirnikr mode of inhibition, although not competitive 
with MMI or thiourea, 1~1s been observed xvith sulfiie 
and thiosulfate 183. Hn consideration of the high 
reactivity of TU towards sulfenyl iodides I-SI) as 
compared with ordinary disulfides [I 13, we suggested 
that an E--S1 complex is formed during deiodination 
171. 
The low activity of MWI in the deiodination of 
iodothyronines in vivo [2] as well as ira vitro [6,8] 
TQ (inacrive prohormone) 
iodinase 
3 ,3’-TZ (inactive) 
rTj (inactive) 
eiodinase 
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compared with its potency sirdar to that of TU in 
inhibiting thyroid peroxidase activity is intrigrring. 
Newertbeless, ah.0 in the iodmation of thyroglobnji,7 
by thyroid peroxidase the formation ofan intermediate 
E-St complex is implied [ 1 l-3 31. Furthermore, it 
has been shown that WMI is even more reactive than 
TU towarcIs P-lactoglobuhn sulfenyl iodide [I I]_ The 
aim of the present study was to elucidate -i:re. features 
in strrrcture of MMI compared with TU rendering it 
virtlnahy without effect on i’ :I: deiodination proc&. 
To this end various analogues of TU and MM1 were 
tested. It was found, among otherthings, that methyla- 
tion of Nr (as in MMI) of thioureylenes greatly 
reduces 5’-deiodinase inhibitory activity_ 
control experiments incubation was carried out 
without microsomes, which are added only following 
the addition of SDS buffer.. Deio&nase activity was 
corrected for the amount of 3,3’iTa produced in the 
controls. The non-snzyinp.tically formed 3,3’-Ta was 
only a minor fraction ofthat produced in the presence 
of microsomes, being generally < 5%_ If necessary, 
test substances were dissolved in 0.1 N NaOM, rapidly 
followed by dilution to the desired concentration 
with incubqtion buffer and adjusting of pH_ 
3. ResnBts 
2. Materials and methods 
2-Thioura+l (TU), 2mercaptopyrimidine, 
2-thiBcytosine, &methyl-TU, 2-thiobarbituric acid, 
Scarboxy-TU and 2thiohydantoin were obtained 
from Sigma, St. Louis, MO. 2-Mercaptobenzimidazole, 
2-mercaptobenzoxazde, 2mercaptobenzothiazole 
and 3-mercapto-B ,2,4-triazole were purchased from 
Fhrka AC, Buchs and I-methyl-2-mercaptoimidazole 
Q&VIII) from Nogepha, Alkmaar. 5-PropyLTU and 
6-propyl-TU were kindly supplied by Dr P. J_ H. Eggels, 
University Hospital ‘Dij2czigt’, Rotterdam. l-Methyl- 
6-propyl-TU was donated by Dr R. H. Lindsay, 
Veterans Administration Hospital, Birmingham, AL 
and 2-mercaptoimidazole by Dr E. BHtisriein, Max- 
Planck-Hnstitut, Heidelberg. 
Conversion of rTa into 3 .,3’-diiodothyronine 
(3,3’-TJ by rat liver microsomal fraction in the 
presence of DTT was studied essentially a5 in [ 143. 
In brief, Q-1 PM rT3 was reacted with 7 @g microsomal 
protein and variorrs substances to be tested in 0.25 ml 
0.05 M phosphate, 3 mM ED’I’A and 1 mM DTT 
(pi-T 6.5). After incubation for 20 min at 37’C, the 
reaction was stopped by the addition of 1 ml 0.06 M 
barbitone bnffer comainning 0.1% bovine serum 
albumin and 0.1% SDS (pN 8.6). The amount of 
3,3’-Ta prodrrced was measured with a specific radio- 
immunnoassay in 50 6.d of the extract [ I§]. The reac- 
tion was started by addition of microsomes. In the 
Figure 1 shows the effect of increasing concentra- 
tions of various TU derivatives on the conversion of 
rTa into 3,3’-T2. The relative activities of these com- 
pounds are given in iable I_ Uracil has been shoun 
not to affect deiodinase activity, pointing to the 
essential nature of the Zmercapto group 171. Similarly, 
deletion of the 4hydroxyi group or replacement Q 
an amino group greatly reduces inhibitory activity. 
(fig.1 ~ table l)_ Polar subsfitnents at C5 and C6 - 
Fig.1 _ Inhibition of the conversion of rTs into 3,3’-T, by 
increasing concentrations of TU derivatives. For details see 
section 2 and for explanation of symbols see table l_ Results 
are mean of 3 closely agreeing experiments performed in 
duplicate. 
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Table B 
Hnhibitory activity of TU defiwatives 
i&ibiftory activiBy of t5iourcd (?pJ) W~CQU~S 
Reldwe 
9 w2 5 Q 
cactivity- 
2-mercopP0pyrimidins H b-i H u-3 < 0.00 1 
v ~~~~~~~~~~~~~~ NHg t-i H H O.OOP 
2-thiowraciB (JU) OH H H H 8.0 
El 5carboxy-TU OH CO*H H H 025 
h 5-prspyl -JU Obi 97 H 
l-i 2.0 
in 6-hydroxy-TUX OH R-i M H Q.08 
0 B-methyi-au OH l-i CH3 H 0.71 
5 
A 6-pmpyl-su (6-P-w) OH M =iP7 H 1.25 B 
5 * 1 -methyl-6-PSU 
OH l-l Gp7 =*a 
<O.OOl 
X2-thiotsarbituric acid 
Figures are based on the concesltratica giving 50% inhibition of deiodinase activity and are expressed relative to that of TU. 
Symbols refer to fig.1 
sspxidy a hydroxyl group at C6 - give a ckxxease in 100 
potency_ Alkyd substituents, on the other hand, do 
not affect activity to a great extent. The most effective 
swbstance is 5propyl-TU, behg twice as active as TU. 
Methylation QfN, yieiids an ahost inactiVe conq3ound. 
The effect oi increashg concentrations of various 
w!lpa41[ z&ogues on the 5’-deiodination of rT3 is ilhs- E 
trated in fig2. The activities of these sunbstencez 
.- 
5 xl 
relative to %hat of TU are given in table 2. For 
I 
c 
comparison, fig.2 shows 2kx3 %he effects of addition of S 
thiourea, which appears to be practically tiactiwe. MI 
has 18% of the activity of 3-U. Hn this case the 25 
hydaowyl subsbitued at OF, is not obl&atory, but even 
Fig.2. hbibition of t!le conversion ofrT, into 3,3*-T, by 
increasing concentrations of MM1 andogues. For details see 
secti:)n 2 anti 2~ expjanation of symbols see table 2; in 
r u I I Y J 
addition, the effect of thick&4 is showpl (n)_ Results are 
8 7 6 5 4 3 
meam of 5 closely agreeing experiments performed in 
duplicate. - log [inhibiter] 
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Table 2 
Inhibitory advity of MM1 ana!ogues 
3uly 1979 
inhibitory activity Of m&imoZOle (MMI) onologves 
HS 
Relative 
X R activity 
0 2-mercopto imibozole (MI) C-H H 0.18 
B l-methyl-MI (A&Al) C-H Cl-l3 <O.OOi 
BD 4-hydroxy-M1X C-OH H 0.035 
H 









&WI~S an? based on the concentration giving 50% inhibition of deiodinase activity and are expressed reiative to that of TU. 
Symbols refer LI fig.2 
lowers inhibitory a~. ___ *++v. As with TU, a methyl main conclusions drawn [33 with regard to the struc- 
substituent at N1 is deleterious. The triazine analogue tural requirements for inhibition of deiodinatioi: by 
hss +2-times the activiiy of MI. The most effective thioureylene derivatives were: 
substance tested is 2-mercap:obenzimidazole, being 1. Substitution of N1 of P!le heterocyck ring as in 
-20~times a; active as hlil and even Simes as active MM1 prevents efFectiveness; 
as T&T_ The importance of the atom occupying posi- 2. An oxygen meta to the thio grcjup in the 6 
tkm B is illustrated by the effects of the blenzothiazole membered ring is essential, but not so for the 5 
and benzoxazole derivatives. The activity of 2-mer- membered ring; 
captobenzimidazole is decreased by 2 and 3 orders of 
magnitude by replackg nitrogen 6th sulfur and 
oSrygen, respectively- 
4. EBi?xpIss~oI1 
The effect of administration of a large number of 
anti-thyroid compounds on the deiodination of T4 in 
the rat in &o was reported [3]. This was investigated 
by rneasuting ehe amount of [‘3’l]iodide excreted in 
‘the urine after the administration of [1311]Te. The 
3_ Polar groups at C6 prevent inhibition of deiodina- 
tion_ 
Among the compounds tested Spropyl-TU was found 
to be the most active. 2-Mercaptobenzimidazole was 
not tested. 
Essentially &e same conclusions may be drawn 
from the present study. This is further strong evidence 
that the enzyme activity investigated in this way is at 
least in part responsible for the deiodination of T4 
in vivo. This would also support the hypothesis that 
5’-deiodination of T3 and other iodotbyronines is 
mediated by this very enzyme [5,14,163. It has been 
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suggested that a secod enzyme mediates 5-deiodina- 
tions [5]1. This 5deiodinase also requires tbiol com- 
pounds for activity ant is also inhibited by TU derva- 
tives [J 0,171. N everthcless, the main effect on thyroid 
hormone deiodination of G$ropyl-T’U in humans is a 
decrea?ed production ofT3 from T4 and a decreased 
degradation of rT3 into 3,3’-T2 [ 161. Thus, it appear 
that iodothyronine §‘.deiodinase is more sensitive 
than the Sdeiodinase to tix administration of ITJ. 
The effects observed 131, therefore, may well have 
been due primarily :o inhibition of 5’-deiodinase 
activity. The dose agreement between their n-mlts 
and ours demonstrates that inhibition of deio,dination 
in viva is due to B direct action on the enzyme of the 
compounds tested and not of their metabolites. The 
inactivity of MMH both in vivo and in vitro suzests 
that no sigd?carit N-demethylation occurs in the 
orgaanim. 
ath MM and thiowea, are potent inhibitors oP 
thyroid peroxidase 121. The stmcturz! requirements 
for thioureylenes to be active inhibitors of thyroid 
peroxidase are, therefore, different from those for 
inhibition of deiodinase activity. Bt has been suggested 
that both inm iodination [ 11-l 31 and deiodinatiom 
[73 the form&ion of an enzyme+ulfenyl iodide 
(E--SB) intermediate is involved. HoweGeT, it is appre- 
ciated that 6propyl TU and MM inhibit pero_xidase 
activity in the absence of iodide [2]. Furthermor$ 
reaction of thiouka and W&II wiPh ~4actogfobulin 
sulfenyl iodide is even faster compared with TU. The 
present study, therefore, has not yielded indica%ons 
for the involvement of an E--SH complex in deiodina- 
Con, Jloweveer plausible thjs mechanism (see section I)_ 
It should be emphasized that the structures drawn 
in ta&s 1 and 2 do not reflect preferred configura- 
tions in aqueous solutions. More likely these are 
represented by (1) for TU and by (2) for 2-mercapto- 
pytimidine. The Patter and those thioureylenes having 
Nr blocked with a methyl group are very weak inhib- 
itors of enzymatic deiodination. .This may suggest 
that there is a strict req<irement for a secondary 
amine in position I_ 
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